Market News

First implementations of Equashield Pro, the only closed system compounding robot, to take place in Europe, following introduction at upcoming industry trade shows: EAHP, HOPA and ISOPP.
Landmark 554-patient Phase 3 study met the primary efficacy endpoint, as 67.2% of AR101 patients ages 4–17 tolerated at least a 600-mg dose of peanut protein in the exit food challenge, compared to 4.0% of placebo patients.
Italian Government regulation supports move to mechanically closed CSTDs for hospitals, replacing filter-based systems.
Eight million copies of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) were downloaded by more than one million people across the globe in 2017.
Proprietary technology enables and helps guide specialty pharmacist interactions with patients prescribed oral oncology medications.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.